Results 211 to 220 of about 510,570 (268)
Some of the next articles are maybe not open access.
Nature Reviews Disease Primers, 2019
Radiotherapy is used in >50% of patients with cancer, both for curative and palliative purposes. Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal tissue can also be damaged, leading to toxicity. Modern and precise radiotherapy techniques, such as intensity-modulated radiotherapy, may prevent toxicity, but some patients ...
Ruysscher, Dirk de +5 more
openaire +4 more sources
Radiotherapy is used in >50% of patients with cancer, both for curative and palliative purposes. Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal tissue can also be damaged, leading to toxicity. Modern and precise radiotherapy techniques, such as intensity-modulated radiotherapy, may prevent toxicity, but some patients ...
Ruysscher, Dirk de +5 more
openaire +4 more sources
Radiotherapy of esthesioneuroblastoma
International Journal of Radiation Oncology*Biology*Physics, 2001Only 3% of all malignant intranasal tumors are esthesioneuroblastomas (ENB). As the tumor is very rare, the number of ENB treated in individual departments is small. In order to evaluate the efficacy of radiotherapy (RT), patients' data of 2 centres were analysed with reference to new reports in literature.From 1981 to 1998, 17 patients with ENB, 8 men
H T, Eich +5 more
openaire +2 more sources
Clinical Orthopaedics and Related Research, 1975
Radiation therapy in the treatment of osteosarcoma has been considered with respect of the subclinical metastatic disease in the lung and the primary lesion. Emphasis is given to the necessity of coordinating the management plan of the primary lesion with an adjuvant program.
openaire +2 more sources
Radiation therapy in the treatment of osteosarcoma has been considered with respect of the subclinical metastatic disease in the lung and the primary lesion. Emphasis is given to the necessity of coordinating the management plan of the primary lesion with an adjuvant program.
openaire +2 more sources
2009
The intrathoracic growth of the tumor causes several severe symptoms as cough, dyspnea, chest pain, hemoptysis, hoarseness, anorexia/nausea, and dysphagia. In patients with manifest or threatening symptoms radiotherapy (RT) as an effective measure should be implemented into the management concept.
openaire +2 more sources
The intrathoracic growth of the tumor causes several severe symptoms as cough, dyspnea, chest pain, hemoptysis, hoarseness, anorexia/nausea, and dysphagia. In patients with manifest or threatening symptoms radiotherapy (RT) as an effective measure should be implemented into the management concept.
openaire +2 more sources
The British Journal of Radiology, 1952
In an endeavour to enlarge the scope of radiotherapy and to improve the results of treatment by a new method, it is imperative to state clearly some of the basic principles underlying the suggested procedure. It seems appropriate therefore to uphold certain fundamentals of radiobiology briefly and to scrutinise whether at any point our present-day ...
openaire +2 more sources
In an endeavour to enlarge the scope of radiotherapy and to improve the results of treatment by a new method, it is imperative to state clearly some of the basic principles underlying the suggested procedure. It seems appropriate therefore to uphold certain fundamentals of radiobiology briefly and to scrutinise whether at any point our present-day ...
openaire +2 more sources
Journal of the American Veterinary Medical Association, 1970
SUMMARY Spontaneous animal tumors of several cell types were irradiated. A 2-year cure-rate was established for tumors in each of 4 cell types by determining the percentage nonrecurrence at 2 years following radiotherapy. The 2-year cure-rates were as follows: perianal tumors, 69%; fibrosarcomas, 56%; squamous cell carcinomas, 74%; and mast cell tumors,
openaire +2 more sources
SUMMARY Spontaneous animal tumors of several cell types were irradiated. A 2-year cure-rate was established for tumors in each of 4 cell types by determining the percentage nonrecurrence at 2 years following radiotherapy. The 2-year cure-rates were as follows: perianal tumors, 69%; fibrosarcomas, 56%; squamous cell carcinomas, 74%; and mast cell tumors,
openaire +2 more sources
Radiotherapy and molecular radiotherapy
2005Abstract Radiotherapy is the use of ionizing radiation (IR) to treat malignant diseases, by damaging and killing tumour cells, for tumour cure or palliation of symptoms. Radiotherapy may also be used in cer- tain benign conditions such as keloid scars, hyper- ostotic new bone formation, and hyperthyroidism.
openaire +1 more source
European Journal of Cancer, 1995
72 patients with either unresectable or pelvic recurrence of colorectal cancer were treated with combined radiotherapy and locoregional hyperthermia. Radiation doses were 50 Gy or more in patients not previously treated with radiotherapy, and 32 Gy (8 x 4 Gy) in patients who had previously received radiotherapy.
González González, D. +2 more
openaire +3 more sources
72 patients with either unresectable or pelvic recurrence of colorectal cancer were treated with combined radiotherapy and locoregional hyperthermia. Radiation doses were 50 Gy or more in patients not previously treated with radiotherapy, and 32 Gy (8 x 4 Gy) in patients who had previously received radiotherapy.
González González, D. +2 more
openaire +3 more sources
Hematology/Oncology Clinics of North America, 2005
Three to four thousand cases of malignant pleural mesothelioma will occur in the United States this year. Single-modality therapy with radiation plays a role for palliation. Radiation can prevent tumor recurrence at drain/instrumentation sites and provide symptomatic relief of pain and other complaints.
Craig W, Stevens +3 more
openaire +2 more sources
Three to four thousand cases of malignant pleural mesothelioma will occur in the United States this year. Single-modality therapy with radiation plays a role for palliation. Radiation can prevent tumor recurrence at drain/instrumentation sites and provide symptomatic relief of pain and other complaints.
Craig W, Stevens +3 more
openaire +2 more sources
2016
Surgery is the primary treatment modality for patients with craniopharyngiomas. Complete surgical excision is associated with a 5-year tumor growth control of 70–90 % in either adult or pediatric series [1, 2]. For uncompleted resected craniopharyngiomas, local control can be improved with the use of radiotherapy (RT) [3–5]. A few retrospective studies
MINNITI, GIUSEPPE, SCARINGI, CLAUDIA
openaire +3 more sources
Surgery is the primary treatment modality for patients with craniopharyngiomas. Complete surgical excision is associated with a 5-year tumor growth control of 70–90 % in either adult or pediatric series [1, 2]. For uncompleted resected craniopharyngiomas, local control can be improved with the use of radiotherapy (RT) [3–5]. A few retrospective studies
MINNITI, GIUSEPPE, SCARINGI, CLAUDIA
openaire +3 more sources